CUSIP: 88338H100
Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
22,189,659
-
Share change
-
+182,312
-
Total reported value
-
$50,785,910
-
Price per share
-
$2.27
-
Number of holders
-
36
-
Value change
-
+$398,842
-
Number of buys
-
14
-
Number of sells
-
15
Quarterly Holders Quick Answers
What is CUSIP 88338H100?
CUSIP 88338H100 identifies THTX - THERATECHNOLOGIES INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2022
-
Previous quarter:
Q1 2022
Recent filing periods for CUSIP 88338H100:
Institutional Holders of THERATECHNOLOGIES INC - COM (THTX) as of Q2 2022
As of 30 Jun 2022,
THERATECHNOLOGIES INC - COM (THTX) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,189,659 shares.
The largest 10 holders included
Soleus Capital Management, L.P., MORGAN STANLEY, AIGH Capital Management LLC, TD Waterhouse Canada Inc., Worth Venture Partners, LLC, CIBC WORLD MARKET INC., ADVISOR GROUP HOLDINGS, INC., STIFEL FINANCIAL CORP, NATIONAL BANK OF CANADA /FI/, and Federation des caisses Desjardins du Quebec.
This page lists
36
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.